Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,187,168 | 4,721,563 | 4,485,271 | 3,703,450 | 3,195,420 |
| Depreciation Amortization | 440,299 | 612,461 | 498,502 | 465,350 | 0 |
| Accounts receivable | -363,667 | -380,492 | -225,831 | -50,112 | N/A |
| Accounts payable and accrued liabilities | -3,422 | 152,981 | 41,497 | 98,150 | N/A |
| Other Working Capital | -263,525 | 193,634 | 105,613 | 278,726 | 81,110 |
| Other Operating Activity | 700,252 | 350,538 | -284,783 | -656,986 | 718,270 |
| Operating Cash Flow | $5,697,105 | $5,650,684 | $4,620,270 | $3,838,579 | $3,994,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 223,200 | 397,966 | 144,439 | -86,573 | N/A |
| PPE Investments | -775,099 | -710,704 | -571,167 | -573,523 | -561,260 |
| Net Acquisitions | 342,686 | N/A | N/A | N/A | 0 |
| Purchase Of Investment | -527,050 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 4,762 | 6,241 | 5,165 | N/A | N/A |
| Purchase Sale Intangibles | -175,882 | -61,514 | -72,309 | -43,200 | N/A |
| Other Investing Activity | -175,882 | -61,514 | -72,309 | -43,200 | -85,220 |
| Investing Cash Flow | $-907,382 | $-368,011 | $-493,871 | $-703,296 | $-646,480 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -86,746 | N/A |
| Common Stock Repurchased | -2,558,765 | -2,615,126 | -2,479,865 | -2,055,629 | N/A |
| Dividend Paid | -1,920,264 | -2,115,708 | -1,730,241 | -1,337,818 | -1,065,330 |
| Other Financing Activity | 0 | 0 | 0 | 1 | -2,074,960 |
| Financing Cash Flow | $-4,479,029 | $-4,730,834 | $-4,210,106 | $-3,480,192 | $-3,140,290 |
| Exchange Rate Effect | 12,797 | 12,124 | -12,467 | -1,382 | -2,990 |
| Beginning Cash Position | 2,034,989 | 1,874,468 | 1,968,539 | 2,256,250 | 2,235,320 |
| End Cash Position | 2,358,480 | 2,438,431 | 1,872,365 | 1,909,958 | 2,440,350 |
| Net Cash Flow | $323,491 | $563,963 | $-96,174 | $-346,291 | $205,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,697,105 | 5,650,684 | 4,620,270 | 3,838,579 | 3,994,800 |
| Capital Expenditure | -777,331 | -711,417 | -576,688 | -582,682 | N/A |
| Free Cash Flow | 4,919,774 | 4,939,267 | 4,043,582 | 3,255,897 | 3,994,800 |